Anti-metastasis effect of thymoquinone on human pancreatic cancer

Yaoxue Xuebao

Volumn 46, Issue 8, 2011, Pages 910-914

  Wu, Zhi Hao ^a   Chen, Zhao ^a   Shen, Yue ^a   Huang, Li Li ^a   Jiang, Ping ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Metastasis; Pancreatic neoplasm; Thymoquinone

Indexed keywords

GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; THYMOQUINONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INVASION; CELL MIGRATION; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; PANCREAS CANCER; TUMOR XENOGRAFT;

ANIMALS; ANTIGENS, CD34; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BENZOQUINONES; CELL LINE, TUMOR; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NF-KAPPA B; NIGELLA SATIVA; PANCREATIC NEOPLASMS; PLANTS, MEDICINAL;

EID: 80053475259     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Jia L, Yuan SZ, Huang WG, et al. An experimental study on therapeutic effects of gemcitabine on human pancreatic carcinoma orthotopically implanted in nude mic [J]. Chin J Hepatobiliary Surg, 2002, 8: 557-559.
2. Banerjee S, Padhye S, Azmi A, et al. Review on molecular and therapeutic potential of thymoquinone in cancer [J]. Nutr Cancer, 2010, 62: 938-946.
3. Gali-Muhtasib H, Kuester D, Mawrin C, et al. Thymoquinone triggers inactivation of the stress response pathway sensor CHEK1 and contributes to apoptosis in colorectal cancer cells [J]. Cancer Res, 2008, 68: 5609-5618.
4. Ravindran J, Nair HB, Sung B, et al. Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential [J]. Biochem Pharmacol, 2010, 79: 1640-1647.
5. Banerjee S, Kaseb AO, Wang Z, et al. Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer [J]. Cancer Res, 2009, 69: 5575-5583.
6. Jafri SH, Glass J, Shi R, et al. Thymoquinone and cisplatin as a therapeutic combination in lung cancer: in vitro and in vivo [J]. J Exp Clin Cancer Res, 2010, 29: 87.
7. Kaseb AO, Chinnakannu K, Chen D, et al. Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer [J]. Cancer Res, 2007, 67: 7782-7788. (Pubitemid 47281372)
8. Su FQ, Li HY, Zhang Y, et al. Effect of Icogenin on and its mechanism in anti-metastasis of pancreatic cancer BxPC3 cells [J]. Acta Pharm Sin, 2009, 44: 456-461.
9. Nagase H, Woessner JF. Matrix metalloproteinases [J]. Biol Chem, 1999, 274: 21491-21494. (Pubitemid 129519680)
10. Bergers G, Brekken R, McMahon G, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis [J]. Nat Cell Biol, 2000, 2: 737-744.
11. Seno H, Oshima M, Ishikawa TO, et al. Cyclooxygenase 2-and prostaglandin E (2) receptor EP (2)-dependent angiogenesis in Ape (Delta716) mouse intestinal polyps [J]. Cancer Res, 2002, 62: 506-511. (Pubitemid 34110434)
12. Yi T, Cho SG, Yi Z, et al. Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways [J]. Mol Cancer Ther, 2008, 7: 1789-1796.
13. Kunnumakkara AB, Guha S, Krishnan S, et al. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products [J]. Cancer Res, 2007, 67: 3853-3861. (Pubitemid 46762173)
14. Farina AR, Tacconelli A, Vacca A, et al. Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappaB elements [J]. Cell Growth Differ, 1999, 10: 353-367. (Pubitemid 29242601)